For those interested in biotech penny stocks, today’s article highlights four to watch, two of which are up over 140% year-to-date. For these four biotech penny stocks – which include a clinical-stage immuno-oncology company focused on innovative treatments and a large producer of COVID-19 tests that, due to its role in helping to fight the pandemic, posted a revenue surge of roughly 33% in the second quarter alone – CLICK HERE.